However, there have been many positives to come out of 2024, which have maybe not grabbed the headlines and gained the ...

A University of Arkansas for Medical Sciences (UAMS) research team has been awarded a $3 million grant from the National ...

Scientists have has pioneered antivirals targeting viral methyltransferases, offering a new strategy for treating RNA and DNA ...

The Centers for Disease Control and Prevention called it the first severe case in the U.S., though the risk to most of the public is still low.

A new type of norovirus is causing a very high number of cases in countries like England, just as a large trial of an mRNA ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.82% ...

A new role has been uncovered for a cell's own RNA in fending off attacks by RNA viruses. Some of the cell's RNA molecules, researchers found, help regulate antiviral signaling. These signals are part ...

Ruben Gonzalez records movies to discover how biomolecules’ motions determine their functions. He has a major new finding.

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly with those kinds ...

Russian experts claim to have developed a mRNA-based vaccine to treat cancer, which will be available for free to patients ...

Russia announces free mRNA cancer vaccine to be distributed in 2025, aiming to reduce tumor size by 80% with AI-assisted ...